The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Frontiers Media S.A.
2011-12-01
|
| Serie: | Oncology Reviews |
| Ämnen: | |
| Länkar: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|